Bessemer Group Inc Tekla Life Sciences Investors Transaction History
Bessemer Group Inc
- $60.7 Billion
- Q3 2024
A detailed history of Bessemer Group Inc transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Bessemer Group Inc holds 937 shares of HQL stock, worth $12,743. This represents 0.0% of its overall portfolio holdings.
Number of Shares
937
Previous 937
-0.0%
Holding current value
$12,743
Previous $13,000
7.69%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding HQL
# of Institutions
77Shares Held
9.31MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$46.6 Million1.1% of portfolio
-
Penserra Capital Management LLC Orinda, CA776KShares$10.6 Million0.25% of portfolio
-
Morgan Stanley New York, NY490KShares$6.66 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY469KShares$6.37 Million0.23% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN417KShares$5.67 Million0.14% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...